We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Portable Nucleic Acid Extraction System Developed For POC Diagnostics

By LabMedica International staff writers
Posted on 31 Jul 2013
A portable, pressure driven, room temperature nucleic acid extraction and storage system for point of care (POC) molecular diagnostics has been developed. More...


A minimally instrumented sample preparation technology yields a purified and thermally stabilized nucleic acid sample that eliminates the cold chain without reducing sensitivity or an increase in downstream processing infrastructure.

Biomedical engineers at Boston University (MA, USA) have developed a whole blood compatible, enzyme-free, ambient temperature, low-pressure nucleic acid extraction process that enables the creation of a completely powerless nucleic acid sample preparation technology. This technology will allow, for example human immunodeficiency virus (HIV) viral load monitoring in low resource areas.

A novel hybrid alcohol precipitation and solid phase extraction process has been presented, utilizing glycogen carrier particles to increase the effective hydrodynamic radius of precipitated nucleic acids aggregates, and a thermally polymerized acrylate based solid phase as a weir for analyte capture. An air pressure driven mechanical system was developed to perform this process in a semiautomated fashion, in order to insulate the process from variations in operator technique. Together, they form the System for Nucleic Acid Purification (SNAP).

The portable system for centrifuge-free room temperature nucleic acid extraction from 70 μL of whole blood uses only thermally stable reagents compatible with storage and transport in low resource settings. Quantitative reverse transcriptase polymerase chain reaction (qRT-PCR) analysis of simulated samples demonstrate a lower limit of detection of 1,000 copies per mL, with the ability to detect differences in viral load across four orders of magnitude.

The device weighs less than 1.36 kg and is capable of extracting HIV-1 viral ribonucleic acid (RNA) directly from virions in whole blood in less than 35 minutes. Samples are stabilized on detachable cartridges, which can be eluted either at the point of care, or transported to a centralized laboratory for further analysis. The study was published on May 13, 2013, in the journal Analytical Methods.

Related Links:

Boston University




New
Gold Member
Serological Pipets
INTEGRA Serological Pipets
Serological Pipet Controller
PIPETBOY GENIUS
New
Clostridium Difficile Toxin A+B Combo Card Test
CerTest Clostridium Difficile Toxin A+B
New
Silver Member
Quality Control Material
Multichem ID-B
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: New research brings hope for improved early detection of pancreatic cancer (Photo courtesy of Adobe Stock)

New Biomarker Panel to Enable Early Detection of Pancreatic Cancer

Pancreatic cancer (PC) has one of the worst prognoses globally, with only 13% of diagnosed patients surviving for five years or more. In Ireland, there are about 900 cases of pancreatic cancer annually,... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: An “evolutionary” approach to treating metastatic breast cancer could allow therapy choices to be adapted as patients’ cancer changes (Photo courtesy of 123RF)

Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer

Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more

Pathology

view channel
Image: A real-time trial has shown that AI could speed cancer care (Photo courtesy of Campanella, et al., Nature Medicine)

AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care

Current cancer treatment decisions are often guided by genetic testing, which can be expensive, time-consuming, and not always available at leading hospitals. For patients with lung adenocarcinoma, a critical... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.